Stock Events

Stock Events

Oruka Therapeutics (HQ1.F) Q3 2024 Earnings

1AugConfirmed

Q3 2024

-0.7

-0.37

-0.04

0.3

Details

Expected EPS

N/A

Actual EPS

-0.70433

Surprise EPS

-0.7

Surprise Percent

+∞%

Description

Oruka Therapeutics (HQ1.F) has reported earnings of -0.70433 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.